Patient adherence and factors influencing quality of life in the case of osteoarthritic patients

Authors

  • Edina Pallagi University of Szeged, Institute of Pharmaceutical Technology and Regulatory Affairs
  • Helga Fekete Institute of Pharmaceutical Technology and Regulatory Affairs, University of Szeged, Faculty of Pharmacy, Szeged, Hungary
  • Róbert Fekete Teaching Hospital – Bács-Kiskun County Hospital, Establishment in Kiskunfélegyháza, University of Szeged, Kiskunfélegyháza, Hungary
  • Ildikó Csóka Institute of Pharmaceutical Technology and Regulatory Affairs, University of Szeged, Faculty of Pharmacy, Szeged, Hungary

DOI:

https://doi.org/10.33892/aph.2019.89.126-132

Keywords:

osteoarthritis, adherence, quality of life.

Abstract

Introduction: 135 million humans are affected by osteoarthritis worldwide, which is going to be doubled by 2020. Current treatment options are limited and complex, requiring the active participation of the patients in order to reach the optimal therapeutic outcome. To date, there is no study available measuring the adherence and quality of life of Hungarian arthritic patients.

Aims: Evaluation of risk factors affecting quality of life and adherence in the case of Hungarian patients, in order to identify the potential intervention points.

Methods: Hospitalized patients’ final reports were analyzed retrospectively (gender, age, BMI, therapy, co-morbidities).

Results: 400 cases were evaluated (females 69%) with an average age of 72 years. 80% of the patients had abnormal BMI. Non-pharmacological treatments ensured the longest asymptomatic period, medication histories showed polypharmacy. Co-morbidities were observed in almost every case.

Conclusion: Patient centeredness is necessary, based on multidisciplinary healthcare team to support the expected quality of life.

 

Published

2020-03-07

How to Cite

(1)
Pallagi, E.; Fekete, H.; Fekete, R.; Csóka, I. Patient Adherence and Factors Influencing Quality of Life in the Case of Osteoarthritic Patients. Acta Pharm Hung 2020, 89, 126-132.

Issue

Vol. 89 No. 4 (2019)

Section

Original Research Articles

Copyright (c) 2019 Acta Pharmaceutica Hungarica

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

APH is published as a diamond open-access journal under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Creative Commons License